Korean J Pediatr Hematol Oncol.  2004 Oct;11(2):164-170.

Epidemiology and Clinical Outcomes of Childhood Wilms Tumor in Korea

Affiliations
  • 1The Korean Society of Pediatric Hematology-Oncology, Korea. cjlyu@yumc.yonsei.ac.kr

Abstract

PURPOSE
Wilms tumor is the most common malignant renal tumor in children. We investigated the epidemiology, clinical features and treatment outcome of the children with Wilms tumor in Korea during the recent 10 years. METHODS: Two hundred forty six patients were enrolled between January 1991 and December 2000 from 26 major hospitals in Korea. The data regarding the clinical features including sex, age, pathologic type, prognostic factor and treatment outcome of patients were analyzed retrospectively by review of patient's medical records. Kaplan-Meier survival curves were constructed, The differences between groups were analyzed by log-rank test. RESULTS: There were 130 males and 116 females. The incidence between the age of 1~4 years was the highest with 66.2%. The annual incidence rate per 1, 000, 000 population varied from 1.9 to 2.1. The 10 years overall survival rate according to sex, clinical stage, pathologic type and relapse were as follows: 88.6% in male, 90.9% in female, 100% in stage I, 94.7% in stage II, 92.1% in stage III, 63.4% in stage IV, 85.7% in stage V, 95.3% in favorable histology, 64.1% in unfavorable histology, 94.8% in non-relapse, and 40.9% in relapse. The relapse rate was 12%. The 10 years overall survival rate of 246 patients were 89.1%. CONCLUSION: Our results could provide the most recent and important clinical information on Wilms tumor of children in Korea.

Keyword

Wilms tumor; Epidemiology; Survival rate; Relapse rate

MeSH Terms

Child
Epidemiology*
Female
Humans
Incidence
Kaplan-Meier Estimate
Korea*
Male
Medical Records
Recurrence
Retrospective Studies
Survival Rate
Treatment Outcome
Wilms Tumor*
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr